XML 67 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Jun. 30, 2012
Cash flows from operating activities:      
Net income $ 99,766 $ 139,701 $ 100,910
Adjustments to reconcile net income to net cash provided by operating activities:      
Loss on extinguishment of debt 7,346    
Depreciation and amortization 133,690 88,272 81,453
Amortization of deferred debt issuance costs 5,053 1,810 1,807
Share-based compensation 14,013 13,380 14,172
Provision for doubtful accounts 3,819 11,173 9,863
Inventory write-downs 12,158 6,130 5,902
Income tax (benefit) expense (16,099) (6,723) (5,986)
Excess tax benefit of stock option exercises (5,106) (18,899) (5,523)
Other 3,065 2,333 3,949
Change in operating assets and liabilities:      
Accounts and notes receivable 7,249 1,084 (35,934)
Inventories (41,694) (54,832) (98,432)
Prepaid and refundable income tax and income tax payable 10,578 19,240 40,802
Other current assets and other assets (4,116) (83) (7,111)
Accounts payable 7,036 (15,484) (2,693)
Accrued liabilities and jackpot liabilities (174) 5,374 15,376
Deferred revenue and deferred cost of revenue (14,709) 12,896 12,428
Net cash provided by operating activities 221,875 205,372 130,983
Cash flows from investing activities:      
Acquisitions, net of cash acquired (1,344,295)   (10,490)
Capital expenditures (24,119) (16,802) (11,464)
Restricted cash and investments (88,957) (1,909) (4,913)
Financing provided to customer   (1,228)  
Payments received from development financing 3,000 223  
Additions to other long-term assets (10,817) (1,932) (8,331)
Net cash used in investing activities (1,465,188) (21,648) (35,198)
Cash flows from financing activities:      
Proceeds from revolving credit facility 660,000 100,000 41,000
Payments on revolving credit facility (130,000) (90,000) (30,000)
Proceeds from long-term debt 1,100,000 100,000  
Payments on long-term debt and capital leases (302,041) (16,964) (15,040)
Capitalized debt issuance costs (36,229) (4,909)  
Acquisition-related contingent consideration (1,394) (1,351)  
Distributions to noncontrolling interests     (82)
Purchase of treasury stock and forward contract (53,526) (292,378) (154,235)
Purchase of series E special stock   (12)  
Excess tax benefit of stock option exercises 5,106 18,899 5,523
Proceeds from exercise of stock options and employee stock purchases 15,561 35,642 25,888
Net cash provided by (used in) financing activities 1,257,477 (151,073) (126,946)
Effect of exchange rate changes on cash 55 (2,104) (2,591)
Cash and cash equivalents:      
Increase (decrease) for year 14,219 30,547 (33,752)
Balance, beginning of year 63,220 32,673 66,425
Balance, end of year $ 77,439 $ 63,220 $ 32,673